Search results

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

The X-ray Fluorescence Nanoprobe beamline undertakes high-resolution X-ray microspectroscopy, elemental mapping and coherent diffraction imaging – providing a unique facility capable of spectroscopic and full-field imaging. Elemental mapping and XANES studies will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using scanning X-ray diffraction microscopy.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.

Highlights of the Energy Materials Project.

The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

Publications and resources from the Powder Diffraction beamline.

Latest information on the scheduled supply of our nuclear medicine production.

Archive of ANSTO research publications, seminars and short talks.

Planning is now underway for a second repatriation project which is scheduled to take place in 2022. Find out more information.